Evidence for a Common Endocannabinoid-Related Pathomechanism in Autism Spectrum Disorders

2013 | journal article???letter_note???. A publication with affiliation to the University of Göttingen.

Jump to: Cite & Linked | Documents & Media | Details | Version history

Cite this publication

​Evidence for a Common Endocannabinoid-Related Pathomechanism in Autism Spectrum Disorders​
Krueger, D. D.   & Brose, N. ​ (2013) 
Neuron, 78(3) pp. 408​-410​.​ DOI: https://doi.org/10.1016/j.neuron.2013.04.030 

Copy

Further links

Documents & Media

License

GRO License GRO License

Details

Authors
Krueger, Dilja D. ; Brose, Nils 
Abstract
In this issue of Neuron, Foldy et al. (2013) report that endocannabinoid-mediated signaling at inhibitory synapses is dysregulated in mouse models of autism-associated Neuroligin-3 mutations. These findings carry implications regarding the pathophysiology of autism spectrum disorders and the development of treatment strategies.
Issue Date
2013
Publisher
Cell Press
Journal
Neuron 
ISSN
0896-6273

Export Metadata

Refman EndNote BibTeX RefWorks Excel CSV

Reference

Citations


Social Media